Abstract

The ATP-grasp superfamily of enzymes shares an atypical nucleotide-binding site known as the ATP-grasp fold. These enzymes are involved in many biological pathways in all domains of life. One ATP-grasp enzyme, d-alanine-d-alanine ligase (Ddl), catalyzes ATP-dependent formation of the d-alanyl-d-alanine dipeptide essential for bacterial cell wall biosynthesis and is therefore an important antibiotic drug target. Ddl is activated by the monovalent cation (MVC) K+, but despite its clinical relevance and decades of research, how this activation occurs has not been elucidated. We demonstrate here that activating MVCs bind adjacent to the active site of Ddl from Thermus thermophilus and used a combined biochemical and structural approach to characterize MVC activation. We found that TtDdl is a type II MVC-activated enzyme, retaining activity in the absence of MVCs. However, the efficiency of TtDdl increased ∼20-fold in the presence of activating MVCs, and it was maximally activated by K+ and Rb+ ions. A strict dependence on ionic radius of the MVC was observed, with Li+ and Na+ providing little to no TtDdl activation. To understand the mechanism of MVC activation, we solved crystal structures of TtDdl representing distinct catalytic stages in complex with K+, Rb+, or Cs+ Comparison of these structures with apo TtDdl revealed no evident conformational change on MVC binding. Of note, the identified MVC binding site is structurally conserved within the ATP-grasp superfamily. We propose that MVCs activate Ddl by altering the charge distribution of its active site. These findings provide insight into the catalytic mechanism of ATP-grasp enzymes.

Highlights

  • The ATP-grasp superfamily of enzymes shares an atypical nucleotide-binding site known as the ATP-grasp fold

  • Through structural investigation of T. thermophilus D-alanine–D-alanine ligase (Ddl), we identified the site responsible for monovalent cation (MVC) activation, the Kϩ cleft, providing the first mechanistic insight into Kϩ activation of

  • Type II MVC activation of TtDdl was confirmed, with activation being dependent on the ionic radius

Read more

Summary

Introduction

The ATP-grasp superfamily of enzymes shares an atypical nucleotide-binding site known as the ATP-grasp fold. One ATP-grasp enzyme, D-alanine–D-alanine ligase (Ddl), catalyzes ATP-dependent formation of the D-alanyl–D-alanine dipeptide essential for bacterial cell wall biosynthesis and is an important antibiotic drug target. We propose that MVCs activate Ddl by altering the charge distribution of its active site These findings provide insight into the catalytic mechanism of ATP-grasp enzymes. D-alanine–D-alanine ligase (Ddl), one of the first characterized ATP-grasp enzymes, catalyzes the energy-dependent conjugation of two D-alanine molecules to form the D-alanyl–Dalanine dipeptide and is essential for cell wall biosynthesis. Because of this important role, Ddl has been primarily investigated as an antibiotic drug target and has been identified as the primary target of the second-line anti-tuberculosis agent D-cycloserine (DCS). The carboxylate of D-Ala attacks the ␥-phosphate of ATP

Objectives
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.